ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 95 filers reported holding ENZO BIOCHEM INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $89,000 | +36.9% | 25,891 | +0.3% | 0.00% | – |
Q4 2020 | $65,000 | +16.1% | 25,822 | -2.8% | 0.00% | – |
Q3 2020 | $56,000 | -8.2% | 26,563 | -2.2% | 0.00% | – |
Q2 2020 | $61,000 | -7.6% | 27,168 | +4.0% | 0.00% | – |
Q1 2020 | $66,000 | -9.6% | 26,124 | -5.5% | 0.00% | – |
Q4 2019 | $73,000 | -27.0% | 27,633 | -0.8% | 0.00% | – |
Q3 2019 | $100,000 | +5.3% | 27,865 | -0.7% | 0.00% | – |
Q2 2019 | $95,000 | +23.4% | 28,059 | -0.1% | 0.00% | – |
Q1 2019 | $77,000 | -4.9% | 28,084 | -3.1% | 0.00% | – |
Q4 2018 | $81,000 | -32.5% | 28,994 | -0.8% | 0.00% | – |
Q3 2018 | $120,000 | -19.5% | 29,216 | +1.8% | 0.00% | -100.0% |
Q2 2018 | $149,000 | -3.2% | 28,691 | +2.0% | 0.00% | 0.0% |
Q1 2018 | $154,000 | -31.9% | 28,136 | +1.4% | 0.00% | 0.0% |
Q4 2017 | $226,000 | -21.8% | 27,743 | +0.5% | 0.00% | 0.0% |
Q3 2017 | $289,000 | +2.5% | 27,612 | +8.1% | 0.00% | 0.0% |
Q2 2017 | $282,000 | +38.2% | 25,548 | +4.6% | 0.00% | 0.0% |
Q1 2017 | $204,000 | +29.1% | 24,432 | +7.1% | 0.00% | 0.0% |
Q4 2016 | $158,000 | -99.9% | 22,822 | -0.3% | 0.00% | – |
Q3 2016 | $116,464,000 | -14.6% | 22,881 | +0.2% | 0.00% | -100.0% |
Q2 2016 | $136,391,000 | +2627.8% | 22,846 | +2184.6% | 0.00% | – |
Q1 2016 | $5,000,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q4 2015 | $5,000,000 | +166566.7% | 1,000 | 0.0% | 0.00% | – |
Q3 2015 | $3,000 | -99.9% | 1,000 | 0.0% | 0.00% | – |
Q2 2015 | $3,030,000 | -95.4% | 1,000 | -95.6% | 0.00% | – |
Q1 2015 | $66,405,000 | -33.6% | 22,510 | 0.0% | 0.00% | – |
Q4 2014 | $99,944,000 | -16.8% | 22,510 | -3.5% | 0.00% | -100.0% |
Q3 2014 | $120,180,000 | -2.5% | 23,336 | -0.6% | 0.00% | 0.0% |
Q2 2014 | $123,260,000 | +2863.0% | 23,478 | +2247.8% | 0.00% | – |
Q1 2014 | $4,160,000 | +42.5% | 1,000 | 0.0% | 0.00% | – |
Q4 2013 | $2,920,000 | +15.9% | 1,000 | 0.0% | 0.00% | – |
Q3 2013 | $2,520,000 | -69.0% | 1,000 | -74.4% | 0.00% | – |
Q2 2013 | $8,127,000 | – | 3,907 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARBERT FUND ADVISORS, INC. | 5,169,337 | $17,420,000 | 25.49% |
Roumell Asset Management, LLC | 1,236,309 | $4,166,000 | 9.86% |
Evermore Global Advisors, LLC | 3,587,251 | $12,089,000 | 2.28% |
CORRADO ADVISORS, LLC | 198,544 | $669,000 | 0.60% |
Fondren Management LP | 175,863 | $593,000 | 0.56% |
MARATHON CAPITAL MANAGEMENT | 247,130 | $832,000 | 0.34% |
KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $322,000 | 0.21% |
EAM Investors, LLC | 178,939 | $603,000 | 0.15% |
Leap Investments LP | 11,811 | $40,000 | 0.05% |
GSA CAPITAL PARTNERS LLP | 75,900 | $256,000 | 0.03% |